SENSEONICS HOLDINGS, INC. (SENS)
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Biodesix Announces First Quarter 2026 Results and Highlights
CPS Technologies Announces First Quarter 2026 Financial Results
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
Omnicell to Present at the BofA Securities 2026 Healthcare Conference
PARAMOUNT REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Advanced Energy Reports First Quarter 2026 Results
McGrath to Participate in the Oppenheimer 21st Annual Industrial Growth Conference
Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees